SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Idenix Pharmaceuticals (IDIX) -- Ignore unavailable to you. Want to Upgrade?


To: tnsaf who wrote (356)11/8/2009 8:28:24 PM
From: DewDiligence_on_SI  Respond to of 412
 
IDIX ‘ReadMeFirst’ updated:

3Q09 financial results;
liquidity and cash usage;
2009-2010 news flow;
phase-2 IDX184 trial begins;
musings on NVS’ IDX184 decision;
GILD’s action on GS9190 may be bullish for IDIX;
GSK/PFE launch HIV JV (includes IDX899);
IDX899 trials completed by GSK or IDIX;
HIV market data from GILD 3Q09 CC;
new version of “HCV: Most Likely to Succeed”;
revised table of biotech buyouts.


siliconinvestor.com